Fate Therapeutics Reports New Employee Inducement Awards

Fate Therapeutics, Inc. reported new employee inducement awards under Nasdaq Listing Rule 5635(c)(4). The company is focused on developing induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for cancer and autoimmune diseases.